Status:
COMPLETED
Clinical Trial For The Treatment Of Chronic Chagas Disease With Posaconazole And Benznidazole
Lead Sponsor:
Hospital Universitari Vall d'Hebron Research Institute
Collaborating Sponsors:
Hospital Vall d'Hebron
Tropical Medicine and International Health Unit Drassanes. Barcelona
Conditions:
Chagas Disease
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
The investigators propose the evaluation of posaconazole and benznidazole in humans for the treatment of Chagas disease chronical infection. Exploratory trial of posaconazole antiparasitic activity ag...
Eligibility Criteria
Inclusion
- Consenting patients with serological evidence of Chagas infection and positive PCR real time
Exclusion
- \-
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2013
Estimated Enrollment :
78 Patients enrolled
Trial Details
Trial ID
NCT01162967
Start Date
September 1 2010
End Date
March 1 2013
Last Update
September 10 2013
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
International Health Unit Metropolitana Nord
Santa Coloma, Barcelona, Spain
2
Infectious Disease Department Vall d'Hebron Hospital
Barcelona, Spain
3
International Health Unit Drassanes
Barcelona, Spain